Latest News for: alks

Edit

ALKS Q4 2025 Earnings Slides FINAL (Alkermes plc)

Public Technologies 25 Feb 2026
). Fourth Quarter and Year-End 2025 Financial Results & Business Update. February 25, 2026. Alkermes in 2026. Strong Foundation for Near- and Long-term Growth and Value Creation ... Alixorexton ... NT1 = narcolepsy type 1 ... FY 2025 Financial Results Summary ... $.
Edit

ALKS Q4 2025 Earnings Release FINAL IR Site (Alkermes plc)

Public Technologies 25 Feb 2026
). Alkermes Contacts.. For Investors. Sandy Coombs +1 781 609 6377. For Media ... 31, 2025 and Provides Financial Expectations for 2026 ... DUBLIN, Feb. 25, 2026 - Alkermes plc(Nasdaq. ALKS) today reported financial results for the quarter and year ended Dec ... $ -.
Edit

Annual General Meeting in ALK-Abell� A/S on 16 March 2026

Nasdaq Globe Newswire 20 Feb 2026
The Annual General Meeting of ALK-Abell� A/S (ALKB.DC / Nasdaq Copenhagen.
Edit

Annual report 2025: ALK delivers 15% revenue growth and 26% EBIT margin

Nasdaq Globe Newswire 20 Feb 2026
ALK’s (ALKB.DC / Nasdaq Copenhagen. ALK B) full-year results came in at the top end of the latest ...
Edit

SPIE supports the low-carbon transition of the ALK pharmaceutical laboratory’s industrial site in Vandeuil (Marne) (SPIE SA)

Public Technologies 05 Feb 2026
A pilot site for ALK's low-carbon transition in Europe ... After analysing the site's technical requirements and constraints, SPIE proposed four scenarios to ALK to reduce CO2 emissions and optimise the site's energy consumption.
Edit

Supplemental deck (ALK Q4 2025 supplemental slides) (Alaska Air Group Inc)

Public Technologies 26 Jan 2026
). ALA KA AiR. O4 2025 Earnings . January 22, 2026. 1. Earnings Update. Q4 2025 and 2024 figures reflect as reported results given Hawaiian's inclusion in Air Group for the full quarter in 2024 ... Unit revenue increased 0.6% in Q4 2025 ... Product. Cargo ... OF ... 4 ... 9.
Edit

ALKS JPM Presentation 2026 FINAL (Alkermes plc)

Public Technologies 12 Jan 2026
). Alkermes 2026.. Driving Profitable Growth in Neuroscience and Leading Orexin Innovation. January 2026. Alkermes in 2026. Strong Foundation for Near- and Long-term Growth and Value Creation ... Alixorexton ... NT1 = narcolepsy type 1 ... >$10 Billion ... *Buysse, D.
Edit

ALK to present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco

Nasdaq Globe Newswire 08 Jan 2026
ALK (ALKB.DC / OMX. ALK B) today announced that the ...
Edit

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alaska Air Group, Inc. - ALK

PR Newswire 11 Dec 2025
NEW YORK, Dec ... ("Alaska Air" or the "Company") (NYSE. ALK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980 ... [Click here for information about joining the class action] ... 7980 ... 21% ... .
Edit

ALK Investors Have Opportunity to Join Alaska Air Group, Inc. Fraud Investigation with the Schall ...

Nasdaq Globe Newswire 10 Dec 2025
ALK Investors Have Opportunity to Join Alaska Air Group, Inc. Fraud Investigation with the Schall Law Firm ... .
Edit

ALK appoints Edward Jordan as new EVP and head of Commercial Operations North America

Nasdaq Globe Newswire 01 Dec 2025
ALK (ALKB.DC / OMX. ALK B) today announced the appointment of Edward Jordan as new Executive Vice ...
Edit

ALK appoints Edward Jordan as new EVP and head of Commercial Operations North America (ALK-Abelló A/S)

Public Technologies 01 Dec 2025
2025-12-01 15.35.00 CET ALK-Abelló - Changes board/management/auditors ALK appoints Edward Jordan as new EVP and head of Commercial Operations North America. ALK (ALKB.DC / OMX ... "I'm honoured to join ALK at this pivotal moment ... ALK-Abelló A/S.
Edit

SMALL ALK

Richmond Times Dispatch 29 Nov 2025
PARENTING . ADVICE ....
Edit

FDA Greenlights Ensartinib: China’s Innovative ALK Inhibitor Enters Global First-Line Lung Cancer Therapy

Pharmiweb 21 Nov 2025
Ensacove) for the treatment of ALK-positive, locally advanced or metastatic non-small cell lung cancer (NSCLC) in adults who have not received prior ALK inhibitor therapy ... Increasing Importance of ALK Targeting.

Article Search

tools
×
×
×
×